2. Cardiovascular Disease

Cardiovascular Disease

Cardiovascular Disease

Related Products

PDF 32.36 MB

Cardiovascular diseases (CVDs) are the leading causes of death and disability worldwide. CVDs include diseases of the heart, vascular diseases of the brain and diseases of blood vessels. Caused by atherosclerosis, coronary heart disease and cerebrovascular disease are the most common forms of CVDs. Other less common forms of CVDs include rheumatic heart disease and congenital heart disease. A large percentage of CVDs is preventable through the reduction of behavioral risk factors such as tobacco use, physical inactivity and unhealthy diet. Dietary sodium reduction can alleviate the long-term risk of cardiovascular disease events. Statin therapy is an effective intervention in both the primary and secondary preventions of CVDs in those who are at high risk.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P3998
    Fibulostatin 6.3 929555-10-2 98%
    Fibulostatin 6.3 is an anti-angiogenic peptide. Fibulostatin 6.3 can be used for the research of anti-angiogenic.
    Fibulostatin 6.3
  • HY-P3999
    Fibulostatin 6.2 945373-84-2 98%
    Fibulostatin 6.2 is an anti-angiogenic peptide that can inhibit migration of human umbilical vein endothelial cells in vitro.
    Fibulostatin 6.2
  • HY-P4000
    Cartilostatin 1 929555-05-5 98%
    Cartilostatin 1 is an anti-angiogenic peptide. Cartilostatin 1 can be used for the research of anti-angiogenic.
    Cartilostatin 1
  • HY-P4001
    Adamtsostatin 4 929554-73-4 98%
    Adamtsostatin 4 is an anti-angiogenic peptide. Adamtsostatin 4 can be used for the research of anti-angiogenic.
    Adamtsostatin 4
  • HY-P4003
    Adamtsostatin 16 929554-90-5 98%
    Adamtsostatin 16 is an anti-angiogenic 17-amino acid peptide containing type I thrombospondin motifs.
    Adamtsostatin 16
  • HY-P4016
    Semastatin 5A.2 929555-16-8 98%
    Semastatin 5A.2 is an anti-angiogenic 19-amino acid peptides that are derived from proteins containing type I thrombospondin motifs.
    Semastatin 5A.2
  • HY-P4017
    Semastatin 5A.1 929555-15-7 98%
    Semastatin 5A.1 is an anti-angiogenic 19-amino acid peptides that are derived from proteins containing type I thrombospondin motifs.
    Semastatin 5A.1
  • HY-P4159
    Endothelin-1 (1-31) (Human) 133972-52-8 98%
    Endothelin-1 (1-31) (Human) is a potent vasoconstrictor and hypertensive agent. Endothelin-1 (1-31) (Human) is derived from the selective hydrolysis of big ET-1 by chymase.
    Endothelin-1 (1-31) (Human)
  • HY-P4201
    JKC 301 136553-96-3 98%
    JKC 301 is a selective Endothelin A receptor antagonist. JKC 301 attenuates the pressor effects of nicotine in rats. JKC 301 can be used to study cardiovascular disease caused by smoking.
    JKC 301
  • HY-P4253
    Arginyl-Glutamine 2483-17-2 98%
    Arginyl-Glutamine is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy.
    Arginyl-Glutamine
  • HY-P4257
    L-Isoleucyl-L-arginine 55715-01-0 98%
    L-Isoleucyl-L-arginine is a dipeptide formed from L-isoleucine and L-arginine residues. L-Isoleucyl-L-arginine is a potent angiotensin-converting enzyme (ACE) inhibitor. L-Isoleucyl-L-arginine can be used for research of hypertension.
    L-Isoleucyl-L-arginine
  • HY-P4259
    Hirullin P18 131147-81-4 98%
    Hirullin P18 is a potent thrombin inhibitor. Hirullin P18 has an anticoagulant effect.
    Hirullin P18
  • HY-P4260
    LPP Tripeptide 121305-26-8 98%
    LPP Tripeptide is a blood pressure lowering tripeptides. LPP Tripeptide can be used for research of hypertension.
    LPP Tripeptide
  • HY-P4269
    Glycylglycylcysteine 95416-30-1 98%
    Glycylglycylcysteine is a Thrombin Activatable Fibrinolysis Inhibitor (TAFI) inhibitor with a Ki of 0.99 μM and a IC50 of 9.4 μM in TAFI substrate assays. TAFI is a basic carboxypeptidase that functions as a fibrinolysis inhibitor through the cleavage of C-terminal lysine on partially degraded fibrin.
    Glycylglycylcysteine
  • HY-P4279
    Ovalbumin (154-159) 1370698-94-4 99.94%
    Ovalbumin (154-159) is a fragment from ovalbumin. Ovalbumin (154-159) is a potent angiotensin-converting enzyme (ACE) inhibitor. Ovalbumin (154-159) can be used for research of hypertension.
    Ovalbumin (154-159)
  • HY-P4281
    Ovotransferrin (328-332) 1226776-54-0 98%
    Ovotransferrin (328-332) has a protective activity on the blood pressure by inhibiting the Angiotensin-Converting Enzyme (ACE), with the IC50 of 20 μM. Ovotransferrin (328-332) fragment has an activity against Cholinesterase (ChE), implicating in Alzheimer’s diseases.
    Ovotransferrin (328-332)
  • HY-P4302
    Z-FK-ck 118253-05-7 98%
    Z-FK-ck (Z-Phe-Lys-2,4,6-Trimethylbenzoyloxy-methylketone) is a potent and selective gingipain-K-specific inhibitor. Z-FK-ck prolongs plasma thrombin time (TT) in a dose- and time-dependent manner.
    Z-FK-ck
  • HY-P4324
    Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 110590-61-9 98%
    Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 is a linear peptide from laminin B1 chain that interferes with tumor cell attachment and invasion into basement membrane and has anti-angiogenic effects.
    Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2
  • HY-P4331
    Boc-Gln-Gly-Arg-AMC 113865-85-3 98%
    Boc-Gln-Gly-Arg-AMC is a fluorogenic substrate for factor XIIa and trypsin. The cleavage of the amide bond between arginine and the methylcoumarin amide group releases fluorescent 7-Amino-4-methylcoumarin (HY-D0027).
    Boc-Gln-Gly-Arg-AMC
  • HY-P4332
    Boc-Glu(OBzl)-Ala-Arg-AMC 113866-16-3 98%
    Boc-Glu(OBzl)-Ala-Arg-AMC is a fluorogenic substrate for coagulation factor XIa and trypsin. The cleavage of the amide bond between arginine and the methylcoumarin amide group releases fluorescent 7-Amino-4-methylcoumarin (HY-D0027).
    Boc-Glu(OBzl)-Ala-Arg-AMC
Cat. No. Product Name / Synonyms Application Reactivity